EKLF Gene Expression in β-thalassemia
Conditionβ-thalassemia
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age5-80
SponsorRofaida Hassan Ahmed
About this trial
1. Studying the effect of expression pattern of EKLF gene in β-thalassemic patients. 2. Detecting the correlation between the gene expression of EKLF and the clinical phenotype of β-thalassemic patients.
Eligibility criteria
Qualifiers
patients with β-thalassemia (major and intermedia).
patients are of both sexes (male or female) at any age
Disqualifiers
patients with any other types of hemolytic anaemia
Trial design
Treatments tested in this trial
- PCR
Treatment groups
150 Participants
are divided into 3 treatment groupsLocations
Sponsors and collaborators
Rofaida Hassan Ahmed
Lead sponsor
Assiut University
Sponsor institution
Source ClinicalTrials.gov